Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

Sung, C; Wei, Y; Watanabe, S; Lee, HS; Khoo, YM; Fan, L; Rathore, AP; Chan, KW; Choy, MM; Kamaraj, US; +11 more... Sessions, OM; Aw, P; de Sessions, PF; Lee, B; Connolly, JE; Hibberd, ML; Vijaykrishna, D; Wijaya, L; Ooi, EE; Low, JG; Vasudevan, SG; (2016) Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients. PLoS neglected tropical diseases, 10 (8). e0004851. ISSN 1935-2727 DOI: https://doi.org/10.1371/journal.pntd.0004851

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pntd.0004851

Abstract

Share

Download

Filename: journal.pntd.0004851.PDF

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar